Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $3.25, but opened at $3.43. Raia Drogasil shares last traded at $3.43, with a volume of 159 shares changing hands.
Raia Drogasil Stock Up 0.3%
The company’s 50 day moving average price is $3.56 and its 200 day moving average price is $4.15.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.05. The firm had revenue of $2.17 billion for the quarter, compared to analyst estimates of $2.32 billion. Sell-side analysts expect that Raia Drogasil S.A. will post 0.17 earnings per share for the current fiscal year.
About Raia Drogasil
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Further Reading
- Five stocks we like better than Raia Drogasil
- Sociedad Química y Minera’s Lithium Boom Is Back, But Iodine Steals the Show
- Forget Chips: These 3 Stocks Are Building the AI Data Center Boom
- AIxCrypto Dumps Its Crypto and Goes All In on Robotics
- AST SpaceMobile’s FCC Test Arrives as Investors Weigh a Costly Q2 Miss
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
